Determination of the in vitro inhibitory effect of experimental antibacterial substances against bacterial pathogens
Ended Awarded
- Contract number
- 75N93024F00001
- Awardee
-
Element Materials Technology Iowa City Inc. UEI GAJDDSFFPD89
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $342,000
Award facts
- Contract value 60% obligated
-
- $342,000.00 Current, with exercised options
- $570,000.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Liberty, IA 52317, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $570K delivery order to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, for determination of the in vitro inhibitory effect of experimental antibacterial substances against bacterial pathogens. The firm fixed-price contract was awarded on May 23, 2024, with an ultimate completion date of May 22, 2025, and will be performed in North Liberty, Iowa. This award falls under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite-delivery/indefinite-quantity contract vehicle and does not utilize a set-aside designation.
JMI Laboratories, a microbiology specialist company registered as a Subchapter S Corporation since 2016, brings substantial expertise in antimicrobial resistance testing and research services to this engagement. The company specializes in in vitro assessments of antimicrobial activity, minimum inhibitory concentration assays, and antimicrobial resistance analysis—critical capabilities for addressing public health challenges related to emerging resistance trends. Through its work under the IVAAA vehicle with NIAID, the company conducts screening for antibacterial activity against pathogens of public health concern and evaluates experimental compounds, supporting the federal government's efforts to develop and validate new antimicrobial therapies.
Quick answers
Who was awarded contract 75N93024F00001?
75N93024F00001 was awarded to Element Materials Technology Iowa City Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 23, 2024.
How much is contract 75N93024F00001 worth?
The government has obligated $342,000 on 75N93024F00001. Its potential value, with all options, is $570,000.
Is contract 75N93024F00001 an order under another contract?
Yes. 75N93024F00001 is a delivery order under 75N93019D00011, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93024F00001 competed?
The extent of competition for 75N93024F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award